CLAREMONT – Kathy Webster was appointed as the founding dean of the KGI School of BioPharmacy.
The school, according to a Jan. 8 news release, is scheduled to admit its first class in fall 2014 pending accreditation.
It’s also being designed to anticipate and meet future needs in the U.S. healthcare system and take advantage of Keck Graduate Institute‘s knowledge in biotechnology education and ties to industry, according to the release.
“Graduates of this school will be very well equipped to meet the needs of a rapidly changing healthcare system in which pharmacists increasingly play a primary role in matching drugs and therapies to a particular patient or strain of illness,” Webster said in a news release. “Graduates of the KGI School of BioPharmacy will be equally well qualified to work in a traditional pharmacy setting, in regulatory affairs or in industry. The philosophy behind the development of the PharmD program at the KGI School of BioPharmacy is to provide the traditional PharmD curriculum in a more efficient manner through the integration of subjects and the extensive use of technology. This will allow us to foster innovation and to increase time spent on content and topics related to industry, including informatics, pharmacogenomics, operations management, clinical and regulatory affairs.”
Webster recently was professor and associate dean of academic affairs at University of Maryland Eastern Shore School of Pharmacy.
Previously, she was assistant dean and chair of pharmaceutical sciences and a professor at Feik School of Pharmacy, University of Incarnate Word in San Antonio, Texas.
“I was intrigued when I heard that KGI, the only graduate school in the country solely dedicated to bioscience education and research, intended to establish a School of BioPharmacy,” Webster said. “I see it as an enormous opportunity to push the education of future pharmacists to a new level.”
Webster has been serving as the school’s interim dean since September 2012.
KGI President Sheldon Schuster said in a statement that: “Dean Webster has great leadership and management abilities and has played an integral role in the successful establishment of several new schools of pharmacy throughout the country. We are very happy to have someone of her caliber as the founding dean of the KGI School of BioPharmacy. We are also very pleased to be able to contribute to the continued development of the Inland Empire and Southern California as a site for scientific, technical and healthcare education.”
According to the release, KGI previously had signed a memorandum of understanding with Chapman University to establish a joint School of BioPharmacy but last month the leadership of both institutions reached the mutual decision to pursue independent schools.